gimp570
Registered: Jan 2003
Posts: 965 |
09-15-10 08:33 PM
for that bad of news...NBIX could not be having a better day
well its either a super strong stock that can shrug off bad news...which are the stocks that can change your life style
or
that drug trial was a long shot to be good and everyone knew it...
i dont know????
Quote from gimp570:
Neurocrine Biosciences Inc. (NBIX)
bad news but its only down a little after hours
i wonder why? anyone have any ideas
Results of statistical analysis using the intent-to-treat population revealed no benefit of GSK561679 compared with placebo on both the Bech Melancholia and HAMD-17 endpoints. The top-line results are based on the six week placebo-controlled portion of the study for the intent to treat population of 145 patients. From a safety perspective, there were no significant adverse events, and the drug was generally well tolerated.
i wonder why? anyone have any ideas
|
